
By BY SUI-LEE WEE from NYT Business https://ift.tt/2X85m0l
via IFTTT A Chinese Covid-19 Vaccine Has Proved Effective, Its Maker Says Sinopharm, a state-controlled company, said its candidate had a 79 percent efficacy rate in interim late-stage trials, bringing a China-made vaccine a step closer to approval for mass use. BY SUI-LEE WEE https://ift.tt/2X85m0l https://ift.tt/3o0fFPL New York Times Business Clinical Trials, Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry December 30, 2020 at 12:17PM
Không có nhận xét nào:
Đăng nhận xét